DTIL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Precision BioSciences Inc (DTIL) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock shows some bullish technical indicators and a potential for short-term gains, the lack of significant positive catalysts, weak financial performance, and no recent trading signals suggest that it is better to hold off on purchasing this stock at this time.
The stock has bullish moving averages (SMA_5 > SMA_20 > SMA_200), a positive MACD histogram of 0.0468, and RSI at 66.059, which is neutral. The key pivot level is 6.5, with resistance at 7.337 and support at 5.663. The stock shows a 70% chance of gaining 11.36% in the next month based on similar candlestick patterns.
Bullish technical indicators, strong options sentiment, and a historical pattern suggesting potential short-term gains.
No recent news or event-driven catalysts. Financial performance shows a significant drop in net income (-213.46% YoY) and EPS (-147.30% YoY). No recent trading activity from hedge funds, insiders, or Congress.
In Q4 2025, revenue increased significantly by 5261.13% YoY to $34.2 million, but net income dropped by -213.46% YoY to $20.13 million, and EPS fell by -147.30% YoY to 1.05. Gross margin remained flat at 100%.
No recent analyst ratings or price target changes available for DTIL.
